Product NDC: | 62211-314 |
Proprietary Name: | Docusate Sodium |
Non Proprietary Name: | Docusate Sodium |
Active Ingredient(s): | 100 mg/1 & nbsp; Docusate Sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, LIQUID FILLED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 62211-314 |
Labeler Name: | A&Z Pharmaceutical, Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part334 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20100915 |
Package NDC: | 62211-314-01 |
Package Description: | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (62211-314-01) |
NDC Code | 62211-314-01 |
Proprietary Name | Docusate Sodium |
Package Description | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (62211-314-01) |
Product NDC | 62211-314 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Docusate Sodium |
Dosage Form Name | CAPSULE, LIQUID FILLED |
Route Name | ORAL |
Start Marketing Date | 20100915 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | A&Z Pharmaceutical, Inc. |
Substance Name | DOCUSATE SODIUM |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes |